Mesoporous Nanoplatform That Efficiently Delivers DOX as an H<sub>2</sub>O<sub>2</sub> Generator to Trigger Mutual Amplification of Cuproptosis and Chemodynamic Therapy
H<sub>2</sub>O<sub>2</sub> in the tumor microenvironment (TME) is a critical mediator for both cuproptosis and chemodynamic therapy (CDT). Enhancing H<sub>2</sub>O<sub>2</sub> levels is thus a promising strategy to optimize the efficacy of these therapeutic approaches. Here, utilizing the H<sub>2</sub>O<sub>2</sub> generation capacity of doxorubicin (DOX), polyacrylic acid (PAA)/CuMnSe nanospheres (NSs) are designed for efficient delivery of DOX to the TME, promoting cuproptosis and CDT simultaneously. The NSs exhibit high DOX-loading capacity (0.97 mg DOX/mg NSs) and pH-responsiveness. The cations (Cu<sup>2+</sup>/Cu<sup>+</sup> or Mn<sup>4+</sup>/Mn<sup>2+</sup>) endow the NSs with cuproptosis and CDT activity, respectively, while CuMnSe acts as a photothermal agent, rendering the NSs near-infrared (NIR)-responsive. Controlled release of DOX in the TME rapidly elevates H<sub>2</sub>O<sub>2</sub> to accelerate two coupled redox reactions underpinning cuproptosis and CDT. Specifically, in cuproptosis, Cu<sup>2+</sup> is reduced by GSH to Cu<sup>+</sup>, which is re-oxidized to Cu<sup>2+</sup> by H<sub>2</sub>O<sub>2</sub> via a Fenton-like reaction. This accelerates the transformation of the oxidation state of copper ions, maximizing the dihydrolipoamide S-acetyltransferase(DLAT)-aggregation induced cuproptosis effects, while GSH is greatly depleted to sensitize the CDT effect. The efficacy of the NSs is evaluated both in vitro and in vivo, demonstrating overall superior anti-tumor efficacy originating from the mutually amplified cuproptosis/CDT effects and the chemotherapy effects of DOX.
Authors
- Yiting Wang (ORCID: https://orcid.org/0000-0002-5700-6441)
- Jian Ma (ORCID: https://orcid.org/0000-0002-9269-1130)
- Wei Tong (ORCID: https://orcid.org/0000-0002-2878-1297)
- Jiaxin Liu (ORCID: https://orcid.org/0000-0002-7908-4934)
- Manjie Zhang (ORCID: https://orcid.org/0009-0006-5527-756X)
- Wei Gao (ORCID: https://orcid.org/0000-0002-6982-9111)
- Hao Wang (ORCID: https://orcid.org/0000-0002-1961-0787)
- Yining Liu (ORCID: https://orcid.org/0000-0003-4006-9996)
- Bo Peng (ORCID: https://orcid.org/0009-0007-9594-2859)
- Bin Sun (ORCID: https://orcid.org/0000-0002-2206-0608)
- Haoyang Du (ORCID: https://orcid.org/0000-0002-6153-3797)
Institutions
- Harbin Medical University (CN)
- Second Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Advanced Healthcare Materials
- Published
- 2025-07-14
- DOI
- https://doi.org/10.1002/adhm.202500933
- Citations
- 4
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 2.70
Funders
- Harbin Medical University
- Heilongjiang Postdoctoral Science Foundation
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Heilongjiang Province